STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[8-K] biote Corp. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

biote Corp. (BTMD) reported that it issued a press release covering financial results for the third quarter ended September 30, 2025. The press release is furnished as Exhibit 99.1 to an Item 2.02 Form 8-K.

The company notes the information is being furnished, not filed, which means it is not subject to Section 18 liability and is not incorporated by reference unless specifically stated.

Positive
  • None.
Negative
  • None.
0001819253false00018192532025-11-052025-11-05

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 05, 2025

 

 

biote Corp.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40128

85-1791125

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1875 W. Walnut Hill Ln #100

 

Irving, Texas

 

75038

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (844) 604-1246

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

 

BTMD

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.02. Results of Operations and Financial Condition.

On November 5, 2025, biote Corp., a Delaware corporation (the “Company”) issued a press release to report the Company’s financial results for the third quarter ended September 30, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Report”).

The information in this Item 2.02 and the attached Exhibit 99.1 are being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall they be deemed to be incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

 

 

Exhibit No.

 

Description

 

 

99.1

 

Press Release, dated November 5, 2025.

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

biote Corp.

 

 

 

 

Date:

November 5, 2025

By:

/s/ Bret Christensen

 

 

 

Bret Christensen
Chief Executive Officer

 


FAQ

What did biote Corp. (BTMD) announce in this 8-K?

The company furnished a press release reporting financial results for the third quarter ended September 30, 2025.

Which period does the BTMD update cover?

It covers the third quarter ended September 30, 2025.

Where can I find the detailed results for BTMD’s Q3 2025?

Details are in Exhibit 99.1, the press release furnished with the Form 8-K.

Is the BTMD information furnished or filed?

It is furnished under Item 2.02 and is not deemed filed or subject to Section 18 liability.

Does the 8-K include the financial figures within the document?

The figures are in the press release attached as Exhibit 99.1; the body of the 8-K does not include them.

What exhibits accompany BTMD’s 8-K?

Exhibit 99.1 (Press Release) and Exhibit 104 (Cover Page Interactive Data File).
Biote

NASDAQ:BTMD

BTMD Rankings

BTMD Latest News

BTMD Latest SEC Filings

BTMD Stock Data

90.01M
28.97M
12.94%
64.25%
2.48%
Medical Care Facilities
Medicinal Chemicals & Botanical Products
Link
United States
IRVING